SEC Form 4 · accession 0001686266-16-000005
ENTELLUS MEDICAL INC · ENTL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian E Farley
Director
Period of report
Dec 7, 2016
Accepted (ET)
Dec 9, 2016 · 5:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374128
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value | Dec 7, 2016 | S | 2,332 | $19.20 | D | 477,249 | D | |
| Common Stock, $0.001 par value | Dec 7, 2016 | S | 919 | $19.10 | D | 476,330 | D | |
| Common Stock, $0.001 par value | Dec 7, 2016 | S | 1,749 | $19.00 | D | 475,581 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.